Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BGM Group Ltd. (BGM) vs Cumberland Pharmaceuticals Inc. (CPIX)

BGM Group Ltd. and Cumberland Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Cumberland Pharmaceuticals Inc. is the larger, with a market value of $120.0M against $104.6M — 1.1× the size. Cumberland Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 4.0×. BGM Group Ltd. has the higher net margin (1.96% vs −26.2%) and the higher return on invested capital (0.00% vs −34.2%). Only Cumberland Pharmaceuticals Inc. pays a dividend (2.07%). Across the 16 metrics below, BGM Group Ltd. leads on 8 and Cumberland Pharmaceuticals Inc. on 8.

Valuation

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
P/E 4.00 n/m 20.14
P/S n/m 2.73 2.25
P/B n/m 6.66 1.90
Price to free cash flow n/m 197.97 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales (0.09) 2.89 2.56
Earnings yield 25.00% (9.33%) (2.99%)
Free cash flow yield 0.00% 0.51% 0.00%

Profitability

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 82.80% 53.94%
Operating margin 0.00% (17.39%) 0.00%
Net margin 1.96% (26.17%) 0.00%
Free cash flow margin 0.00% 1.38% 0.00%
Return on equity 0.00% (48.76%) (0.40%)
Return on assets 0.00% (16.70%) (3.32%)
Return on invested capital 0.00% (34.23%) 0.00%

Growth

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 31.98% 10.01%
EPS growth (last fiscal year) 10.00% 58.70% —
Revenue growth, 5-year CAGR (5.39%) 3.52% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 1.25 0.96 2.31
Net debt to EBITDA 0.97 (4.58) 0.85

Dividend

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% 2.07% 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BGM CPIX Drug Manufacturers Specialty & Generic median
Market cap 104.61m 120.01m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack